Search HLYK
HealthLynked Corp
OTC · CIK 1680139
Last close2.3
Daily change-0.02 (-0.86%)
10 Years gain-93.43%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
HLYK · STANDARD
SIC 8011 · Services-Offices & Clinics of Doctors of Medicine · Fiscal year end 1231
Fundamental
32.9Momentum
n/aAcceleration
n/aConfidence
64.0Annual Revenue6
Quarterly Revenue18
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth9.7 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet9.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Key Metrics
Revenue Growth TTM20.15%OK
Revenue CAGR 3Y-22.64%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $2.07M | -$2.11M | -$1.71M | n/a | n/a | n/a | n/a | n/a | 2.84M |
| 2025 FY Dec 31, 2024 | n/a | $3.01M | -$4.68M | -$3.49M | -$3.50M | n/a | n/a | n/a | n/a | 2.82M |
| 2024 FY Dec 31, 2024 | $3.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2024 FY Dec 31, 2023 | $5.72M | $5.72M | -$4.15M | -$4.14M | -$4.15M | 100% | -72.55% | -72.46% | -767.16% | 262.89M |
| 2023 FY Dec 31, 2022 | $5.86M | n/a | -$8.66M | -$4.36M | -$4.39M | n/a | -147.82% | -74.88% | -287.37% | 243.42M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $3.72M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-24-098383, 0001213900-24-043561 |
| Revenue Growth TTM | 20.15% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-24-098383, 0001213900-24-043561 |
| Revenue CAGR 3Y | -22.64% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-25-026262 |
| Revenue CAGR 5Y | -5.63% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-25-026262 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 0.48x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |
| Gross Margin Delta 3Y | n/a | GrossMargin_current - GrossMargin_3Y_ago | INSUFFICIENT_HISTORY | derived |